Jing Liu

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 14

Top Topics

Placebo Controlled

Top Venues

Clinical and translational science

CPT: pharmacometrics & systems pharmacology

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Jim H Hughes, Richard Bertz, Rajinder Bhardwaj, Mary K Donohue, Jennifer Madonia, Matt S Anderson, Beth A Morris, Robert S Croop, Jing Liu
Concentration-QTc and cardiac safety analysis of single and multiple zavegepant nasal spray doses in healthy participants to support approval. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Rajinder Bhardwaj, Michael S Hanna, Beth A Morris, Kyle T Matschke, Richard Bertz, Robert S Croop, Jing Liu
No clinically relevant electrocardiogram effects in a randomized TQT study of single therapeutic/supratherapeutic rimegepant doses in healthy adults. Clinical and translational science 17 (3) (2024)
Jim H Hughes, Richard Bertz, Rajinder Bhardwaj, Mary K Donohue, Jennifer Madonia, Matt S Anderson, Beth A Morris, Robert S Croop, Jing Liu
Concentration-QTc and cardiac safety analysis of single and multiple zavegepant nasal spray doses in healthy participants to support approval. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Jing Liu, Karen Rowland-Yeo, Almut Winterstein, Simon Dagenais, Qi Liu, Jeffrey S Barret, Rui Zhu, Cyrus Ghobadi, Amita Datta-Mannan, Joy Hsu, Sujatha Menon, Mariam Ahmed, Pooja Manchandani, Paulien Ravenstijn
Advancing the utilization of real-world data and real-world evidence in clinical pharmacology and translational research-Proceedings from the ASCPT 2023 preconference workshop. Clinical and translational science 17 (4) (2024)
Rajinder Bhardwaj, Mary K Donohue, Jennifer Madonia, Beth A Morris, Thomas C Marbury, Kyle T Matschke, Robert Croop, Richard Bertz, Jing Liu
Reduced hepatic impairment study to evaluate pharmacokinetics and safety of zavegepant and to inform dosing recommendation for hepatic impairment. Clinical and translational science 17 (7) (2024)
Jing Liu, Karen Rowland-Yeo, Almut Winterstein, Simon Dagenais, Qi Liu, Jeffrey S Barret, Rui Zhu, Cyrus Ghobadi, Amita Datta-Mannan, Joy Hsu, Sujatha Menon, Mariam Ahmed, Pooja Manchandani, Paulien Ravenstijn
Advancing the utilization of real-world data and real-world evidence in clinical pharmacology and translational research-Proceedings from the ASCPT 2023 preconference workshop. Clinical and translational science 17 (4) (2024)
Jim H Hughes, Richard Bertz, Rajinder Bhardwaj, Mary K Donohue, Jennifer Madonia, Matt S Anderson, Beth A Morris, Robert S Croop, Jing Liu
Concentration-QTc and cardiac safety analysis of single and multiple zavegepant nasal spray doses in healthy participants to support approval. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Rajinder Bhardwaj, Michael S Hanna, Beth A Morris, Kyle T Matschke, Richard Bertz, Robert S Croop, Jing Liu
No clinically relevant electrocardiogram effects in a randomized TQT study of single therapeutic/supratherapeutic rimegepant doses in healthy adults. Clinical and translational science 17 (3) (2024)
Jim H Hughes, Richard Bertz, Rajinder Bhardwaj, Mary K Donohue, Jennifer Madonia, Matt S Anderson, Beth A Morris, Robert S Croop, Jing Liu
Concentration-QTc and cardiac safety analysis of single and multiple zavegepant nasal spray doses in healthy participants to support approval. CPT: pharmacometrics & systems pharmacology (2024)
Rajesh Krishna, Bernard Sebastien, Solange Corriol-Rohou, S Y Amy Cheung, Jing Liu, Satyendra Suryawanshi
Pediatric Rare Diseases Development in the Pharmaceutical Industry: An International Consortium for Innovation and Quality in Pharmaceutical Development, Clinical Pharmacology Leadership Group-Pediatrics Working Group, Rare Diseases Subteam Whitepaper Examining the Current Landscape and Recommendations for the Future. Clinical pharmacology and therapeutics (2024)
Rajinder Bhardwaj, Mary K Donohue, Jennifer Madonia, Beth A Morris, Thomas C Marbury, Kyle T Matschke, Robert Croop, Richard Bertz, Jing Liu
Reduced hepatic impairment study to evaluate pharmacokinetics and safety of zavegepant and to inform dosing recommendation for hepatic impairment. Clinical and translational science 17 (7) (2024)
Rajinder Bhardwaj, Mary K Donohue, Jennifer Madonia, Beth A Morris, Thomas C Marbury, Kyle T Matschke, Robert Croop, Richard Bertz, Jing Liu
Reduced hepatic impairment study to evaluate pharmacokinetics and safety of zavegepant and to inform dosing recommendation for hepatic impairment. Clinical and translational science 17 (7) (2024)
Jing Liu, Karen Rowland-Yeo, Almut Winterstein, Simon Dagenais, Qi Liu, Jeffrey S Barret, Rui Zhu, Cyrus Ghobadi, Amita Datta-Mannan, Joy Hsu, Sujatha Menon, Mariam Ahmed, Pooja Manchandani, Paulien Ravenstijn
Advancing the utilization of real-world data and real-world evidence in clinical pharmacology and translational research-Proceedings from the ASCPT 2023 preconference workshop. Clinical and translational science 17 (4) (2024)
Rajinder Bhardwaj, Michael S Hanna, Beth A Morris, Kyle T Matschke, Richard Bertz, Robert S Croop, Jing Liu
No clinically relevant electrocardiogram effects in a randomized TQT study of single therapeutic/supratherapeutic rimegepant doses in healthy adults. Clinical and translational science 17 (3) (2024)